To assess LDL-C control (less than 55 mg/dL) in patients with ACS with current available treatments.
Not Applicable
Completed
- Conditions
- Health Condition 1: I249- Acute ischemic heart disease, unspecified
- Registration Number
- CTRI/2022/05/042446
- Lead Sponsor
- ovartis Healthcare Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 575
Inclusion Criteria
1. Patients aged >18 years. 2. Patients with ACS event [One or more of the following: ST-segment-elevation myocardial infarction or left bundle branch block myocardial infarction (STEMI/LBBB MI), a non-ST-segment-elevation myocardial infarction (NSTEMI), or UA with or without PCI/ CABG. 3. Lipid profile data available at index date/15 days of index date and at least once at 3, 6, 9, 12 months post-index date ACS event.
Exclusion Criteria
Patients meeting any of the following criteria will not be included in the study: 1. Incomplete paper-based records/EMRs data. 2. Non-availability of paper-based records/EMRs for 12 monthsâ?? time point post index date ACS event.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method